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Abstract
Drosophila melanogaster is widely used to decipher the innate immune system in response to various pathogens. The innate
immune response towards persistent virus infections is among the least studied in this model system. We recently discovered
a picorna-like virus, the Nora virus which gives rise to persistent and essentially symptom-free infections in Drosophila
melanogaster. Here, we have used this virus to study the interaction with its host and with some of the known Drosophila
antiviral immune pathways. First, we find a striking variability in the course of the infection, even between flies of the same
inbred stock. Some flies are able to clear the Nora virus but not others. This phenomenon seems to be threshold-dependent;
flies with a high-titer infection establish stable persistent infections, whereas flies with a lower level of infection are able to
clear the virus. Surprisingly, we find that both the clearance of low-level Nora virus infections and the stability of persistent
infections are unaffected by mutations in the RNAi pathways. Nora virus infections are also unaffected by mutations in the Toll
and Jak-Stat pathways. In these respects, the Nora virus differs from other studied Drosophila RNA viruses.
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Introduction
The ultimate goal for viruses is to survive and propagate within
its host. They do that either by infecting and propagating in a
consecutive series of individual hosts, usually causing overt disease
or death, or by infecting and persisting in a single host for a longer
period of time. In the latter case, viruses need to infect the cells,
manipulate the host replication machinery to replicate their
genomes and get released from the infected cells without killing the
host or triggering the immune system. Whereas some DNA- and
retroviruses are able to persist by integrating their DNA into the
host genome, it is still unclear how persistence is maintained by
RNA viruses and by what mechanisms they evade the immune
defense of the host.
In mammals, the innate and adaptive immune mechanisms act
together to protect the host from viral infections. By contrast, the
fruit fly Drosophila melanogaster, which lacks an adaptive immune
system, depends entirely on the innate immune response. The
absence of an adaptive immune response and the tractable
genetics available in Drosophila melanogaster makes it a valuable
model system to study the role of innate immunity in controlling
viral infections.
It is still not fully understood how Drosophila controls viral
infections. The Jak-Stat pathway has been shown to affect the
course of Drosophila C virus infection [1], and there is some
evidence for a role of the Toll pathway during an infection with
the Drosophila X virus [2]. Best established is the role the RNAi
machinery in the defense against RNA viruses [3,4,5,6,7].
The RNAi machinery uses small RNAs as guides to target
complementary RNA and initiate the silencing of its expression.
These small RNAs are divided into three groups: small interfering
RNAs (siRNA), microRNAs (miRNA) and the piwi-associated
interfering RNAs (piRNA) [8]. The siRNAs are directed towards
viral or other exogenous double-stranded RNA, causing degrada-
tion of the complementary RNA. In contrast, miRNAs are
directed towards endogenous mRNA and are involved in the
regulation of mRNA expression. Finally, the piRNAs are
important in the control of retrotransposons and are encoded in
the germline of Drosophila [9].
In Drosophila two different RNase III enzymes, Dicer 1 and Dicer
2, process the double-stranded RNA to produce the miRNA and
siRNA duplexes respectively [10]. Dicer-2 was shown to be a major
factor in determining the outcome of an infection by several
positive-strand RNA viruses: Drosophila C virus, flock house virus,
cricket paralysis virus and the Sindbis virus [4,6,7]. The viral
double-stranded RNA is cleaved by Dicer-2 into siRNAs of 21–23
nucleotides in length. The resulting siRNAs are then loaded onto a
multiprotein complex, the RNAi-induced silencing complex
(RISC), which contains a member of the Argonuate (AGO) family,
AGO2, Vasa intronic gene (VIG) and potentially other associated
proteins [11]. The guide strand of the siRNA, which bears
complementarity with the target RNA, directs the highly specific
cleavage of viral RNA molecules. Other components in the RNAi
machinery have also been shown to play a role. For example, a
mutation in R2D2, a double-stranded RNA-binding protein
required downstream of Dicer-2, results in an increased flock house
virus titer [6]. Flies deprived of essential components of the RNAi
pathway also showed increased sensitivity to the Drosophila X virus, a
double-stranded RNA virus. Moreover the virus appeared to
replicate faster in cells deprived of AGO2 than in wild-type cell [3].
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viral double-stranded RNAandinducing Vago, whichparticipatesin
the control of viral titers in the fat body [12].
The best-characterized Drosophila viruses are all pathogenic,
causing acute lethality or increased mortality in the infected stocks
[2,13,14,15,16,17]. In contrast, the Nora virus, a picorna-like virus
recently identified in Drosophila melanogaster, causes persistent
infections that are virtually asymptomatic [18,19]. The Nora virus
can therefore be used as a model to study the interaction of a
persistent infection with the immune system of its host. In this
report, we used the Nora virus to study the characteristics of the
persistent infection and its interaction with the known anti-viral
defenses in Drosophila. We observed a large variability in the ability
of individual flies to clear the virus, depending on the viral titer in
the infected fly. Surprisingly, we found that none of the known
antiviral responses in Drosophila seems to play any role against the
Nora virus.
Materials and Methods
Fly strains
All flies used were 3–5 days old and were reared at 25uCo n
standard yeast/agar media. Oregon R and Canton S flies were used
as wild-type flies. The AGO2
51B [20], AGO2
414 [21], r2d2
S165fsX
[6,22], Dcr-1
Q1147X and Dcr-2
L811fsx [23], piwi
1 and piwi
2 [24], hop
Tum
[25] and pll
2 [26] fly stocks have been described previously.
Viral infection protocol
Flies were infected by injection as described in [18]. Briefly,
infected flies were homogenized in 1 ml NT buffer (100 mM
NaCl, 10 mM Tris-HCl, pH 7.4), and clarified by centrifugation
at 13,2006g for 5 min at 4uC. The supernatant was filtered
through a 0.2 mm filter and the filtered preparation was used for
infection of flies. Flies were anesthetized by CO2 and approxi-
mately 0.1 ml of the viral suspension was injected in the thorax.
Flies were allowed to lay eggs during 7–10 days after the infection,
and the viral titers were quantified in the offspring to confirm that
we had established a permanently infected stock.
RNA preparation and quantitative PCR
Total RNA was prepared using the Aurum total RNA kit
(BioRad), according to the manufacturer. Quantitative RT-PCR
was performed in duplicate, using the probe detection system in an
I-cycle iQ Thermal Cycler (BioRad). The probe-based quantitative
PCR was done with the following primers: forward, 59-
TTTCACTTTACTGTTGGTCTCC-39; reverse, 59-ATTC-
CATTTGTGACTGAT-TTTATTTC-39 and a FAM/TAMRA
probe: 59-FAM-AGAGTTAGTGGACAA-GTTAGAGACTGG-
CAT-TAMRA-39. cDNA synthesis was performed at 50uC for
10 min and 95uC for 3 minutes, followed by 40 cycles of
amplification at 95uC for 10 seconds and 55uC for 30 seconds.
The probe-based protocol works at an efficiency of 85%, and this
value was used to calculate the relative concentration of viral RNA.
Quantification of virus secretion in feces
To follow the viral production in single flies, we collected the
feces of flies kept individually in 1.5 ml centrifuge tubes containing
fly food. After 24 hours the flies were transferred to a new tube
with fresh fly food. The same procedure was repeated daily during
at least 19 days. We isolated viral RNA from the feces deposited in
the tubes during days 1, 2, 3, 4, 7, 14 and 19. Total RNA was
prepared using the Aurum total RNA kit (BioRad), after vortexing
the feces deposited on the wall of the centrifuge tubes, with RNA
extraction buffer (BioRad). For the clearance experiments, five
days old single flies were kept in bottles and transferred twice per
day into fresh bottles.
Results
Variability of Nora virus titers
We observed a large variability in the Nora virus titers between
individuals of the same infected stock. The titers vary by three
orders of magnitude [18] and Fig. 1a], suggesting that some flies
may be able to clear the virus. To further investigate this possibility
we minimized the re-infection via the fecal-oral route by keeping
individual flies in separate vials, and transferring them twice per
day to fresh food. After four days (Fig. 1b) or fourteen days
Figure 1. Nora virus clearance. Viral RNA in single flies kept (A) four days on contaminated food (unflip), or serially transferred for (B) four and (C)
fourteen days to clean food (flip). Every dot represents the quantification from a single fly. OR: Oregon R, CS. Canton S, n.d: not detected.
doi:10.1371/journal.pone.0005731.g001
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this treatment further enhanced the individual differences in viral
titers. One population of flies retained the high titers of viral RNA,
10
6–10
7 arbitrary units, whereas a second population showed low
or undetectable titers (typically 10–100 arbitrary units). Only few
flies had intermediate titers. Similar results were seen with Oregon
R (OR) and Canton S (CS) flies.
Clearance of the Nora virus over time
We hypothesized that these individual variations in viral titers
could be related to the replication cycle of the virus, causing bursts
of viral production in the flies. To test this possibility, we next
followed the virus production in single flies over time, by
determining the virus titers in their feces. We transferred
individual flies to fresh tubes with fly food every 24 hrs, and then
quantified the viral RNA deposited in the tube during that time
period (Fig. 2). This experiment clearly shows that there are no
cyclic bursts of viral production. Instead, flies that deposited large
amounts of virus on day one, also continued to produce virus at a
relatively constant rate during all the examined days. In contrast,
flies that produced less virus at the start of the experiment showed
a dramatic further reduction in viral production during the first
four days. Thereafter the viral deposition continued to decrease,
but at a slower rate. A few flies were of medium titer, but they
tended to either increase or decrease their viral production,
approaching the high- or low-titer populations. This result
excludes the possibility that the individual differences in virus
titer are due to viral replication cycle. These results further
demonstrate the persistence characteristics of the Nora virus,
which is able to maintain a constant and high rate of viral
production in some individuals, during a significant fraction of
their life span. At the same time, other individuals appear to be
able to fight the virus, although 19 days in this setting is not
sufficient to clear the infection entirely.
Nora virus and RNAi
The clearance of the virus in individuals of an infected stock,
allowed us to study whether any of the known innate immune
pathways are important in controlling the Nora virus. To study
this question, we established Nora virus-infected stocks with
mutations that affect these pathways. Such infected mutant flies
were transferred to fresh food twice per day during four days, and
then the viral titers in the flies was assayed to see the effect of the
mutations on the clearance of the virus in low-titer infected flies,
and on the persistence in the flies with a high-titer infection.
We first tested homozygous null mutants of the AGO2, Dicer-2,
and r2d2 genes, which are all essential for the siRNA pathway and
known to affect other Drosophila RNA viruses. Surprisingly, we
observed no difference in the ability of these mutants to clear the
Nora virus after an infection compared to the wild-type stocks
(Fig. 3). For all mutants, a significant fraction of the individuals
manage to clear the virus, fully or in part. Nor did we observe
increased viral titers or any obvious lethality caused by the Nora
virus in these mutants. From these experiments we conclude that
the siRNA pathway does not significantly affect Nora virus
persistence or clearance.
We also tested two different null mutants in piwi, which is
involved in the control of retrotransposon RNA precursors via the
piRNA pathway. Again, we saw no difference between piwi
mutants and wildtype flies in their ability to clear the virus (Fig. 3).
Finally, we also tested a null mutant in Dicer-1 gene, which is
important in the miRNA machinery that controls endogenous
mRNA. Dicer-1 is required for normal development, and the Dcr-
1
Q1147X mutant is therefore homozygous lethal, but at least in the
heterozygous condition it does not affect the viral titers (Fig. 3).
Nora virus and other immune pathways
Since the Toll and Jak-Stat pathways have also been implicated
in controlling viral infections in Drosophila, we finally investigated if
these pathways affect the Nora virus. For the Toll pathway we
tested a strong loss-of-function allele in the pelle gene, pll
2, which
blocks Toll signaling when homozygous. However, that did not
affect the ability of the mutant flies to clear the virus (Fig. 3). Thus,
we conclude that the Toll pathway does not play a significant role
in the interaction between the Nora virus and its host. Null
mutants in the Jak-Stat pathway are homozygous lethal. Instead
we tested a gain-of-function mutant, hop
Tum, which has a
continuously activated Jak-Stat pathway. However, Fig. 3 shows
that hop
Tum flies have normal Nora virus titers. That experiment
does not exclude the possibility that Jak-Stat signaling might play a
role, but it is clearly not sufficient to affect the Nora virus.
Discussion
Our data show that the Nora virus is able to establish a
persistent infection in the individual fly for a long period of time.
This persistence seems to be determined by the virus titer in a
threshold-dependent manner. A high-titer infection tends to
stabilize at a high level, resulting in a persistent infection. On
the other hand, flies with a lower titer seem to be more efficient in
fighting the infection and reducing the initial viral load. Our
experimental approach allowed us to test for two possible levels of
Nora virus infection control. First, a mutation that inactivates the
antiviral defense should result in flies that are unable to clear a
low-titer infection. As a consequence, we expect all flies in the
population to become persistently infected. Second, if the defense
also limits viral replication in the persistently infected flies, we
could expect increased viral titers and perhaps lethality. Surpris-
ingly, none of these effects were observed for any of the mutants
Figure 2. Clearance is threshold-dependent. Viral RNA secreted
during 24 hrs in feces of single flies, serially transferred to clean food.
Every line represents a single fly followed during 19 days. n.d: not
detected.
doi:10.1371/journal.pone.0005731.g002
Nora Virus Unaffected by RNAi
PLoS ONE | www.plosone.org 3 May 2009 | Volume 4 | Issue 5 | e5731we tested. A fraction of the flies in all tested stocks were able to
clear the virus, fully or in part, and another fraction reached a
similar level of persistent infection as in the wild-type controls.
The lack of effect of the siRNA system was unexpected. This
system is generally active against foreign replicating RNA and it is
known to be essential in the defense against several RNA viruses in
different organisms. It is possible that the Nora virus produces a
suppressor of the siRNA-dependent RNAi machinery, or that it
uses a stealth approach to avoid triggering the antiviral response.
Viral suppressors of RNAi have been described from several viral
systems [8], but we found no sequence in the Nora virus genome
that is related to the viral suppressors that have been described
previously. It should be noted however, that even the production
of an RNAi inhibitor does not necessarily make a virus entirely
resistant to the RNAi machinery, as shown for the flock house
virus and the Drosophila C virus [6,7]. These viruses remain
partially inhibited by the machinery even though they encode
RNAi inhibitors, as mutational inactivation of the RNAi
machinery leads to increased viral loads and enhanced virulence.
To our knowledge, there is no evidence of an RNAi inhibitor that
could render the virus completely insensitive to the RNAi
machinery. Further experiments are needed to determine whether
the Nora virus encodes such an efficient inhibitor. We also failed to
find any role for the two other main pathways of the RNAi
machinery, or for Toll and Jak-Stat signaling. A caveat is that we
could not test the null phenotypes of the developmentally essential
miRNA and Jak-Stat pathways.
Although persistently infected flies produce Nora virus at a very
high and stable rate, on the order of 10
8 viral genomes per hour,
viral replication is never so high that the survival of the host is
endangered [18]. This balance might be influenced by defense
mechanisms of the host, but the stability of the system is not in
itself an argument for the existence of an antiviral defense in
Drosophila against the Nora virus. If the virus carries its own
mechanisms to limit replication, such a balance could be reached
even in the complete absence of effective defenses. This situation
would be ideal for the virus, where it would be able to evade the
immune system and control its titers to levels that would maintain
its presence by transmission to the next generation via the fecal-
oral route. However, the clearance of the Nora virus from the low-
titer flies is on the other hand a strong indication that defense
mechanisms do exist in Drosophila, as it is unlikely that the virus
encodes a mechanism for its own elimination.
The existence of both, a high variability in viral titers within the
infected fly populations and a threshold titer that determines the
persistence of the virus, makes us think that the immune system
does interact with the Nora virus and influences the outcome of
the infection. It remains to be determined by which mechanisms
the flies clear the virus. To our knowledge this is the first example
of an RNA virus that is completely unaffected by the inactivation
of the RNAi machinery. It is also intriguing that the virus is not
sensitive to any of the other immune pathways that have been
shown to be important during an infection with other Drosophila
viruses. Further genetic studies in Drosophila and in the Nora virus
are likely to resolve these issues.
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